GxPinnacle Logo
Skip to content

What Do Inspectors Check for Training Delivery, Records and Evidence in Pharmacovigilance?

Pharmacovigilance training must be delivered, recorded, and evidenced in a controlled manner. Regulators expect traceable training records, documented completion, defined delivery methods, and audit-ready evidence that required training was actually completed.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance training must be delivered through defined and controlled methods.
  • Completion of required training must be recorded and traceable at individual level.
  • Training records must show what was delivered, when it was completed, how it was delivered, and who provided it.
  • Evidence of attendance, completion, assessment, or certification must be retained where applicable.
  • Training records must be complete, secure, and readily retrievable for audit or inspection.
  • Inspection-ready evidence must demonstrate that required training was not only assigned, but actually completed and documented.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Training delivery must be documented.
  • Completion of training must be traceable to the individual.
  • Training records must show what was completed and when.
  • Evidence of training completion must be retained.
  • Training records must be available for audit and inspection.

Summary

Inspectors assess whether pharmacovigilance training is delivered through controlled methods and supported by complete records. They review training logs, completion evidence, delivery methods, and whether the organisation can prove that required training was actually completed and retained in an audit-ready format.

Common questions

These are the questions this page is designed to answer directly.

  • How is pharmacovigilance training documented?
  • What do inspectors check for PV training records?
  • What evidence is required for training completion in pharmacovigilance?
  • How are training records maintained in PV systems?
  • What training delivery methods are acceptable in pharmacovigilance?
  • How do you prove staff completed pharmacovigilance training?
  • What is a training record in pharmacovigilance?
  • How do regulators assess training documentation?
  • What should a PV training log contain?
  • How do you keep audit-ready training evidence?

Evidence objects inspectors expect

Training Delivery Records

  • Documented training sessions with topic, date, and trainer
  • Defined delivery methods such as classroom, webinar, e-learning, or on-the-job training
  • Attendance records for instructor-led sessions
  • Evidence that training was delivered as planned

Training Record Log

  • Employee name, department, and position
  • Training title, training date, and completion date
  • Training method and trainer or provider
  • Certification or assessment outcome where applicable
  • Comments on retakes, quiz scores, or exceptions

Completion and Assessment Evidence

  • Signed attendance sheets or e-signatures
  • Learning management system completion records
  • Quiz or knowledge check results
  • Certificates of completion for formal courses

Training Materials and Supporting Records

  • Training slides, modules, or reference materials
  • Version-controlled training content
  • Linked evidence showing what content was delivered
  • Archived copies of historical training materials where relevant

Record Retention and Retrieval Controls

  • Secure storage of training records
  • Defined retention periods for training documentation
  • Ability to retrieve records by employee, role, or topic
  • Audit-ready access to training evidence

Regulatory Basis (Primary Sources)

  • GVP Module I – personnel performing PV activities must be trained and documented as competent
  • GVP Module II – documentation must support operation of the PV system and inspection readiness
  • ICH E2D – personnel handling safety data must be appropriately trained and supported by documented processes
  • MHRA GPvP guidance – expectations for documented training records and competence evidence
  • FDA 21 CFR Part 11 – electronic training records and evidence must be controlled and traceable where maintained electronically

Typical Inspection Questions (What Inspectors Ask)

  • Show me the training records for this employee.
  • How do you prove this training was completed?
  • What method was used to deliver this training?
  • Where are your training records stored?
  • How quickly can you retrieve training evidence during an inspection?

Failure patterns

Training is delivered but not documented adequately.

Training records are incomplete, inconsistent, or missing key fields.

The organisation cannot prove that required training was completed.

Assessment or certification evidence is not retained where relevant.

Training records are not easily retrievable during audits or inspections.

What good looks like

  • Complete and traceable training records for all required training.
  • Clear evidence of training completion by individual.
  • Documented delivery methods and trainer information.
  • Assessment or certification records retained where applicable.
  • Secure, audit-ready training records that can be retrieved quickly.

Operationalisation

  • Use a controlled system or log to record all training completion.
  • Capture employee identity, training topic, dates, method, and provider for each training activity.
  • Retain completion evidence such as attendance records, LMS logs, or certificates.
  • Store training materials and records in a secure and retrievable format.
  • Verify that training evidence matches assigned training requirements.
  • Review record completeness regularly as part of training governance.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

How is pharmacovigilance training documented?

Pharmacovigilance training is documented through training records that capture the employee, training topic, delivery method, training date, completion date, trainer, and any assessment or certification outcome.

What evidence is needed to prove training completion in pharmacovigilance?

Evidence may include signed attendance sheets, LMS completion records, quiz results, certificates, webinar logs, or other controlled records showing that the training was completed.

What should a PV training record include?

A PV training record should include the employee's identity, role, training title, delivery date, completion date, method of training, trainer or provider, and any certification or comments relevant to completion.

Do inspectors review pharmacovigilance training records?

Yes. Inspectors frequently review training records to confirm that required training was completed, documented properly, and linked to the individual's role.

How long should pharmacovigilance training records be kept?

Training records should be retained for the period defined in the company's document retention policy and any applicable regulatory requirements, while remaining secure and retrievable.

Why is training evidence important in pharmacovigilance?

Training evidence is important because it proves that personnel were trained and competent to perform PV activities, which is a core expectation during audits and inspections.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module II
    View source

FDA

ICH

MHRA